Biotechnology Journal · 2021 · 15 citations · 13 references
Life SciencesBiochemistryInfectious DiseasesComparative Infectious DiseasesMolecular VirologyVirologyAnimal VirusesViral ClearanceViral InfectionsViral PathogenesisViral PersistenceVirus-host InteractionsEnveloped Virus ClearanceLow Ph InactivationNon-enveloped Virus ClearancePh DependenceTherapeutic Protein ManufacturingViral Clearance MechanismsViral InactivationVirus Inactivation Mechanisms
BACKGROUND: Virus inactivation is a critical operation in therapeutic protein manufacturing. Low pH buffers are a widely used strategy to ensure robust enveloped virus clearance. However, the choice of model virus can give varying results in viral clearance studies. Pseudorabies virus (SuHV) or herpes simplex virus-1 (HSV-1) are frequently chosen as model viruses to demonstrate the inactivation for the herpes family. RESULTS: In this study, SuHV, HSV-1, and equine arteritis virus (EAV) were used to compare the inactivation susceptibility at pH 4.0 and 4°C. SuHV and HSV-1 are from the same family, and EAV was chosen as a small, enveloped virus. Glycine, acetate, and citrate buffers at pH 4.0 and varying buffer strengths were studied. The inactivation susceptibility was found to be in the order of SuHV > HSV > EAV. The buffer effectiveness was found to be in the order of citrate > acetate > glycine. The smaller virus, EAV, remained stable and infectious in all the buffer types and compositions studied. CONCLUSION: The variation in inactivation susceptibility of herpes viruses indicated that SuHV and HSV cannot be interchangeably used as a virus model for inactivation studies. Smaller viruses might remain adventitiously infective at moderately low pH.
13
Lauren Platts, Robert J. Falconer · International Journal of Pharmaceutics · 2015 · 83 citations · Full text
Virus Isoelectric Point Determination Using Single-Particle Chemical Force Microscopy
Xue Mi, Emily K. Bromley, Pratik U. Joshi et al. · Langmuir · 2019 · 57 citations